Injection Pen Market Size To Reach $60.7 Billion By 2030

Injection Pen Market Growth & Trends

The global injection pen market size is expected to reach USD 60.7 billion by 2030, according to a new report by Grand View Research, Inc., registering a 7.4% from 2025 to 2030. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.

Injectable pens have witnessed significant success in improving patient convenience during management of chronic disease, a process that might include administering intermittent injections. These devices are more convenient and affordable than other delivery systems. Ongoing studies on the same to assess their applications in management of other diseases, including but not limited to Hepatitis C and cancer, is expected to ensure swift market growth through 2025.

 Request a free sample copy or view report summary: Injection Pen Market Report

Injection Pen Market Report Highlights

• The reusable segment accounted for the largest revenue share of 70.4% in 2024 and is expected to grow at the fastest CAGR over the forecast period due to the growing focus on environmental sustainability in the healthcare industry.

• The hospital segment dominated the market with the largest revenue share of 39.4% in 2024, due to the quick acceptance and boost from the rise in government efforts to enhance healthcare infrastructure and the increasing population of diabetes patients within the evaluated timeframe.

• North America dominated the injection pen market and accounted for a 44.7% share in 2024. The rising occurrence of non-communicable diseases, such as diabetes, cancer, cardiovascular conditions, and multiple sclerosis in countries like Canada and the U.S. is a major factor driving the growth of the market.

Injection Pen Market Segmentation

Grand View Research has segmented the global injection pen market on the basis of product, application, end use, and region:

Injection Pen Product Outlook (Revenue, USD Million, 2018 - 2030)

• Disposable

• Reusable

Injection Pen Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes

• Anaphylaxis

• Osteoporosis

• Growth Hormone Deficiency

• Arthritis

• Others

Injection Pen End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

• Clinics

• Home Care Settings

Injection Pen Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Injection Pen Market

• BD

• Eli Lilly and Company

• Ypsomed AG

• Biocon

• Pfizer Inc.

• Novartis AG

• Novo Nordisk A/S

• Sanofi

• Owen Mumford Ltd.

• Merck KGaA